The development of immunotherapies for non-small cell lung cancer

By Salgaller Michael L  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 265-278

Informa Healthcare

Access to resources Recommend Favorite

The role of talactoferrin alfa in the treatment of non-small cell lung cancer

By Kelly Ronan J   Giaccone Giuseppe  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 9, 2010-09 ,pp. : 1379-1386

Informa Healthcare

Access to resources Recommend Favorite

A review of vaccine clinical trials for non-small cell lung cancer

By Nemunaitis J   Nemunaitis J  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 89-102

Informa Healthcare

Access to resources Recommend Favorite

Ipilimumab (MDX-010) in the treatment of non-small cell lung cancer

By Genova Carlo   Rijavec Erika   Barletta Giulia   Sini Claudio   Dal Bello Maria Giovanna   Truini Mauro   Murolo Carmelina   Pronzato Paolo   Grossi Francesco  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 939-948

Informa Healthcare

Access to resources Recommend Favorite

Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549

By Wang Ying  

Molecular Biology Reports, Vol. 40, Iss. 4, 2013-04 ,pp. : 3093-3099

Springer Publishing Company

Access to resources Recommend Favorite